19-48318481-C-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001364171.2(ODAD1):āc.266G>Cā(p.Arg89Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00104 in 1,551,646 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R89Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_001364171.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ODAD1 | NM_001364171.2 | c.266G>C | p.Arg89Pro | missense_variant | 5/16 | ENST00000674294.1 | |
ODAD1 | NM_144577.4 | c.155G>C | p.Arg52Pro | missense_variant | 3/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ODAD1 | ENST00000674294.1 | c.266G>C | p.Arg89Pro | missense_variant | 5/16 | NM_001364171.2 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00168 AC: 256AN: 152164Hom.: 6 Cov.: 31
GnomAD3 exomes AF: 0.00395 AC: 615AN: 155732Hom.: 18 AF XY: 0.00380 AC XY: 314AN XY: 82612
GnomAD4 exome AF: 0.000975 AC: 1365AN: 1399364Hom.: 23 Cov.: 31 AF XY: 0.000955 AC XY: 659AN XY: 690192
GnomAD4 genome AF: 0.00168 AC: 256AN: 152282Hom.: 6 Cov.: 31 AF XY: 0.00189 AC XY: 141AN XY: 74460
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Benign:2
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 19, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 18, 2017 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Primary ciliary dyskinesia 20 Benign:1
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 14, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at